National Institutes of Health: all 11,571 studies

Page 88 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic MethodsCompletedNCT00022919
• Prevention of Steroid-Induced Osteoporosis in ChildrenTerminatedNCT00022841Phase 1/2
• 3-D Laser Imaging to Analyze Neck MovementStatus unknownNCT00022828
• Management of Compartment Syndrome With UltrafiltrationCompletedNCT00022815Phase 1
• Image Guided System for Orthopaedic SurgeryTerminatedNCT00022802Phase 2
• Randomized Trial of Health Events Costs in Diabetic BlacksCompletedNCT00022750Not applicable
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00022737Phase 3
• Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00022581Phase 2
• Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related LymphomaCompletedNCT00022555Phase 1
• BMS-247550 in Treating Patients With Advanced Soft Tissue SarcomaTerminatedNCT00022542Phase 2
• BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid TumorsCompletedNCT00022529Phase 1
• Tipifarnib in Treating Young Patients With Refractory LeukemiaCompletedNCT00022451Phase 1
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous TreatmentCompletedNCT00022438Phase 2
• Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck CancerStatus unknownNCT00022373Phase 3
• EMD 121974 in Treating Patients With Advanced Solid TumorsCompletedNCT00022113Phase 1
• Immunotoxin Therapy in Treating Patients With Hairy Cell LeukemiaCompletedNCT00021983Phase 1
• ESCAPE Mechanistic Substudies - Ancillary to ESCAPECompletedNCT00021957
• Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic ControlCompletedNCT00021944
• Modification of Allergic Immunologic Response by Leukotriene Antagonists - Ancillary to ACRN IMPACTCompletedNCT00021931
• Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNTCompletedNCT00021918
• Atrial Fibrillation Incidence, Risk Factors and GeneticsCompletedNCT00021905
• Visceral Adiposity and CVD Risk in WomenCompletedNCT00021879
• Motor Training to Treat Hand DystoniaCompletedNCT00021853Phase 2
• PTHrP and OsteoporosisCompletedNCT00021827Phase 2
• Medical Therapy of Prostatic SymptomsCompletedNCT00021814Phase 3
• Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free RegimenCompletedNCT00021801Phase 2
• Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free ImmunosuppressionCompletedNCT00021788Phase 2
• HIV Prevention Preparedness Study in Russia, China, and IndiaCompletedNCT00021775
• Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIVWithdrawnNCT00021762Phase 2
• Motor Learning in Stroke Patients and Healthy VolunteersCompletedNCT00021710
• Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV TransmissionCompletedNCT00021671Phase 3
• Effects of Pesticide Exposure on Neurodevelopment/Growth/Respiratory HealthCompletedNCT00021658Not applicable
• Vitamin E to Treat Uveitis-Associated Macular EdemaCompletedNCT00021645Phase 1
• Effects of Ribavirin on Zidovudine or StavudineCompletedNCT00021632
• Modification of the "Edmonton Protocol" to Allow for Successful Islet Transplantation From a Single Pancreas and Extension of the "Edmonton Protocol" to Kidney Transplant RecipientsStatus unknownNCT00021580Phase 1
• A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex InfectionsCompletedNCT00021567Phase 2
• Sequenced Treatment Alternatives to Relieve Depression (STAR*D)CompletedNCT00021528Phase 4
• Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV TreatmentWithdrawnNCT00021489Phase 2
• Changing to Nonprotease Inhibitor Treatment to Improve Side EffectsCompletedNCT00021463Phase 2
• Biological Significance of the Bloom's Syndrome ProteinCompletedNCT00021437
• Vaccine Therapy in Treating Patients With Stage IV Head and Neck CancerCompletedNCT00021424Phase 1
• Bortezomib in Treating Children With Advanced Solid TumorsCompletedNCT00021216Phase 1
• Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00021164Phase 2
• Ixabepilone in Treating Patients With Advanced Urinary Tract CancerCompletedNCT00021099Phase 2
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00021073Phase 1
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung CancerCompletedNCT00021060Phase 2/3
• Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorCompletedNCT00021047Phase 1/2
• Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00020709Phase 3
• A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's SarcomaTerminatedNCT00020683Phase 2
• Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for CancerCompletedNCT00020631Not applicable
• MS-275 in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00020579Phase 1
• Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney CancerCompletedNCT00020540Phase 1
• Caspofungin Acetate in Treating Children With Fever and NeutropeniaCompletedNCT00020527Not applicable
• Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the LiverCompletedNCT00020501Phase 3
• Combination Chemotherapy in Treating Patients Who Have Advanced Solid TumorsCompletedNCT00020488Phase 1
• Vaccine Therapy in Treating Patients With Metastatic Melanoma of the EyeCompletedNCT00020475Phase 2
• Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular LymphomaCompletedNCT00020462Phase 1
• Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00020449Phase 2
• Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast CancerCompletedNCT00020410Phase 1
• Vaccine Therapy in Treating Patients With Refractory Metastatic MelanomaCompletedNCT00020397Phase 2
• BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous TherapyCompletedNCT00020371Phase 1
• Vaccine Therapy in Treating Patients With MelanomaCompletedNCT00020358Phase 2
• Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the PancreasCompletedNCT00020345Phase 2
• Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00020332Phase 1/2
• Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00020267Phase 1
• Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate CancerCompletedNCT00020254Phase 2
• FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung CancerCompletedNCT00020202Phase 2
• Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00020189Phase 2
• Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast CancerCompletedNCT00020176Phase 2
• Temozolomide and O6-benzylguanine in Treating Children With Solid TumorsCompletedNCT00020150Phase 1
• Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the LungsCompletedNCT00020124Phase 1
• Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or LymphomaCompletedNCT00020111Phase 1
• Complementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast CancerCompletedNCT00020098Not applicable
• Analysis of Genes Present in Cutaneous T-cell Lymphoma CellsCompletedNCT00020072Not applicable
• Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate CancerCompletedNCT00020046Phase 2
• Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By SurgeryCompletedNCT00020007Phase 1
• Vaccine Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00019994Phase 2
• Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or LegCompletedNCT00019968Phase 2
• Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)CompletedNCT00019955Phase 2
• Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00019929Phase 2
• Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian CancerCompletedNCT00019916Phase 1/2
• Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic MelanomaCompletedNCT00019890Phase 2
• Combination Chemotherapy Before and After Surgery in Treating Patients With OsteosarcomaTerminatedNCT00019864Phase 2
• UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or LeukemiaCompletedNCT00019838Phase 1
• Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the PleuraCompletedNCT00019825Phase 1
• Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2CompletedNCT00019812Phase 2
• Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesCompletedNCT00019786Phase 2
• Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel CancerCompletedNCT00019773Phase 1
• Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the LiverCompletedNCT00019760Phase 2
• Vaccine Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00019734Phase 2
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00019721Phase 2
• Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaTerminatedNCT00019708Phase 1
• Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate CancerTerminatedNCT00019695Phase 2
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00019669Phase 2
• Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic CancerCompletedNCT00019656Phase 1
• Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast CancerTerminatedNCT00019643
• Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 1
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal CancerCompletedNCT00019591Phase 1/2
• Stereotactic Radiosurgery in Treating Patients With Brain TumorsCompletedNCT00019578Phase 1
• PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis TherapyCompletedNCT00019565Phase 1

← National Institutes of Health overview and focus areas